Moderna MRNA is expected to report first-quarter 2025 earnings on May 1, before the opening bell. The company’s earnings beat ...

Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

Learn more about whether Amicus Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...

such as lyme and norovirus vaccines. Receive News & Ratings for Moderna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ...

Learn more about whether Moderna, Inc. or Zai Lab Limited is a better investment based on AAII's A+ Investor grades, which ...

The UK Health Security Agency has issued a warning for people to stay at home for 48 hours if they exhibit symptoms of the norovirus, such as vomiting and diarrhoea. The agency has reported that ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Moderna. Looking at options history for Moderna MRNA we detected 13 trades. If we consider the specifics of each trade ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of $32.00. The company’s shares closed yesterday ...

I beg to disagree! Diarrhea viruses can linger around toilets. I have been reading about norovirus and the amount of virus that can be spread during an attack. When I see how dirty many public ...

2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19, influenza, respiratory syncytial virus (RSV), ...